natgillin/translations-raw huggingface dataset:
Each coated tablet contains 170 mg lactose (as monohydrate).
Ena obložena tableta vsebuje 170 mg laktoze (v obliki monohidrata).
If CIALIS is prescribed, a careful individual benefit/risk evaluation should be undertaken by the prescribing physician.
Če zdravnik predpiše zdravilo CIALIS, mora skrbno ovrednotiti razmerje med koristmi in tveganjem pri posamezniku.
CIALIS is a treatment for adult men with erectile dysfunction.
Kaj je zdravilo CIALIS in za kaj ga uporabljamo Zdravilo CIALIS je namenjeno zdravljenju odraslih moških z erektilno disfunkcijo.
Light yellow and almond shaped tablets, marked "C 5" on one side.
Tablete svetlo rumene barve in mandljeve oblike, z oznako “C 5” na eni strani.
Each tablet contains 10 mg of tadalafil.
Ena tableta vsebuje 10 mg tadalafila.
This is when the prostate gland gets bigger with age.
Pri tem obolenju se prostata z leti povečuje.
If CIALIS is prescribed once-a-day, a careful individual benefit/risk evaluation should be undertaken by the prescribing physician.
Če zdravnik predpiše zdravilo CIALIS za odmerjanje enkrat na dan, mora skrbno ovrednotiti razmerje med koristmi in tveganjem pri posamezniku.
For CIALIS on demand, three clinical studies were conducted in 1054 patients in an at-home setting to define the period of responsiveness.
Opravljene so bile tri klinične študije za določitev obdobja odzivnosti na zdravilo CIALIS, v katere je bilo vključenih 1054 bolnikov v domačem okolju.
Men with hepatic impairment
Moški z okvaro jeter
NAME OF THE MEDICINAL PRODUCT CIALIS 20 mg tablets tadalafil
IME ZDRAVILA CIALIS 20 mg tablete tadalafil
QUALITATIVE AND QUANTITATIVE COMPOSITION CIALIS 10 mg film-coated tablets Each tablet contains 10 mg tadalafil.
CIALIS 10 mg filmsko obložene tablete Ena tableta vsebuje 10 mg tadalafila.
Although specific interactions have not been studied, other protease inhibitors, such as saquinavir, and other CYP3A4 inhibitors, such as erythromycin, clarithromycin, itraconazole and grapefruit juice should be co-administered with caution as they would be expected to increase plasma concentrations of tadalafil (see section 4.4).
Čeprav specifičnih medsebojnih delovanj niso preučevali, je potrebno druge zaviralce proteaze, kot je sakvinavir, ter druge zaviralce CYP3A4, kot so eritromicin,
Do not take CIALIS if you:
Kaj morate vedeti, preden boste vzeli zdravilo CIALIS Ne jemljite zdravila CIALIS, če:
Once-a-day dosing of tadalafil is not recommended in patients with severe renal impairment (see sections 4.4 and 5.2).
Pri bolnikih s hudo okvaro ledvic je največji priporočeni odmerek 10 mg. Odmerjanje tadalafila enkrat na dan ni priporočljivo za bolnike s hudo okvaro ledvic (glejte poglavji 4.4 in 5.2).
It is not known if CIALIS is effective in patients who have undergone pelvic surgery or radical non-nervesparing prostatectomy.
učinkovito pri bolnikih po operacijah v medenici ali po radikalni prostatektomiji brez ohranjanja živcev.
MARKETING AUTHORISATION NUMBER(S) EU/1/02/237/001-005, 009
ŠTEVILKA (ŠTEVILKE) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/02/237/001-005, 009
Tadalafil at doses of 2 to 100 mg has been evaluated in 16 clinical studies involving 3250 patients, including patients with erectile dysfunction of various severities (mild, moderate, severe), etiologies, ages (range 21-86 years), and ethnicities.
3250 bolnikov, vključno z bolniki z erektilno disfunkcijo različnih resnosti (blaga, zmerna, huda), etiologij, starosti (razpon 21-86 let) in narodnosti.
Rare (seen in 1 to 10 in every 10,000 patients) - fainting, seizures and passing memory loss, swelling of the eyelids, red eyes, sudden decrease or loss of hearing, hives (itchy red welts on the surface of the skin), penile bleeding, presence of blood in semen and increased sweating.
- omedlevica, epileptični napadi in začasna izguba spomina, otekanje vek, rdeče oči, nenadno poslabšanje ali izguba sluha, koprivnica (srbeče rdeče maroge na površini kože), krvavitev iz penisa,
Three clinical studies were conducted in 1054 patients in an at-home setting to define the period of responsiveness to CIALIS on demand.
Opravljene so bile tri klinične študije za določitev obdobja odzivnosti na zdravilo CIALIS zaužito po potrebi, v katerih je bilo vključenih 1054 bolnikov v domačem okolju.
MARKETING AUTHORISATION NUMBER(S) EU/1/02/237/006
ŠTEVILKA (ŠTEVILKE) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/02/237/006
Visual defects and cases of NAION have been reported in connection with the intake of CIALIS and other PDE5 inhibitors.
Vid V povezavi z jemanjem zdravila CIALIS in drugih zaviralcev PDE5 so poročali o okvarah vida in primerih NAION.
NAME OF THE MEDICINAL PRODUCT CIALIS 2.5 mg film-coated tablets
IME ZDRAVILA CIALIS 2,5 mg filmsko obložene tablete
For oral once-a-day use.
Za peroralno uporabo enkrat na dan.
CIALIS 20 mg film-coated tablets
CIALIS 20 mg filmsko obložene tablete tadalafil
MARKETING AUTHORISATION NUMBER(S) EU/1/02/237/001
ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/02/237/001
CIALIS 10 mg film-coated tablets
CIALIS 10 mg filmsko obložene tablete tadalafil
MARKETING AUTHORISATION NUMBER(S) EU/1/02/237/002-005, 009
ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/02/237/002-005, 009
NAME OF THE MEDICINAL PRODUCT CIALIS 10 mg tablets tadalafil
IME ZDRAVILA CIALIS 10 mg tablete tadalafil
A medical history and physical examination should be undertaken to diagnose erectile dysfunction and determine potential underlying causes, before pharmacological treatment is considered.
Preden začnemo razmišljati o farmakološkem zdravljenju, je za diagnozo erektilne disfunkcije in določitev možnih temeljnih vzrokov potrebno vzeti anamnezo in pregledati bolnika.
NAME OF THE MEDICINAL PRODUCT CIALIS 5 mg film-coated tablets
IME ZDRAVILA CIALIS 5 mg filmsko obložene tablete
NAME OF THE MEDICINAL PRODUCT CIALIS 2.5 mg tablets tadalafil
IME ZDRAVILA CIALIS 2,5 mg tablete tadalafil
What CIALIS looks like and contents of the pack CIALIS 20 mg is a yellow film-coated tablet in the shape of an almond and has "C 20" marked on one side.
Tablete CIALIS 20 mg so rumene filmsko obložene tablete v obliki mandlja in imajo na eni strani oznako "C 20".
CIALIS 2.5 mg film-coated tablets Tadalafil
CIALIS 2,5 mg filmsko obložene tablete tadalafil
General disorders and administration site conditions Chest pain1, Peripheral oedema, Fatigue
Splošne težave in spremembe na mestu aplikacije bolečina v prsnem košu1, periferni edem, utrujenost otečen obraz2, nenadna srčna smrt1,2
See leaflet for further information.
laktoza Za nadaljnje informacije glejte navodilo za uporabo!
CIALIS 5 mg film-coated tablets Tadalafil
CIALIS 5 mg filmsko obložene tablete tadalafil
Once-a-day administration either for the treatment of erectile dysfunction or benign prostatic hyperplasia has not been evaluated in patients with hepatic insufficiency.
Pri bolnikih z jetrno insufienco niso ocenjevali odmerjanja enkrat na dan za zdravljenje erektilne disfunkcije ali benigne hiperplazije prostate.
Warnings and precautions Talk to your doctor before taking CIALIS.
Pred začetkom jemanja zdravila CIALIS se posvetujte z zdravnikom.
NAME OF THE MEDICINAL PRODUCT CIALIS 5 mg tablets tadalafil
IME ZDRAVILA CIALIS 5 mg tablete tadalafil
What CIALIS looks like and contents of the pack CIALIS 10 mg is a light yellow film-coated tablet in the shape of an almond and has "C 10" marked on one side.
Tablete CIALIS 10 mg so svetlo rumene filmsko obložene tablete v obliki mandlja in imajo na eni strani oznako "C 10".
What CIALIS looks like and contents of the pack CIALIS 5 mg is a light yellow film-coated tablet in the shape of an almond and has "C 5" marked on one side.
Tablete CIALIS 5 mg so svetlo rumene filmsko obložene tablete v obliki mandlja in imajo na eni strani oznako "C 5".
Visual field defect, Swelling of eyelids, Conjunctival hyperaemia, Nonarteritic anterior ischemic optic neuropathy (NAION) 2, Retinal vascular occlusion2
nearterična anteriorna ishemična optična nevropatija (NAION) zapora retinalnih žil2
Yellow and almond shaped tablets, marked "C 20" on one side.
CIALIS 20 mg filmsko obložene tablete Tablete rumene barve in mandljeve oblike, z oznako "C 20" na eni strani.
Tadalafil is > 10,000-fold more potent for PDE5 than for PDE1, PDE2, and PDE4, enzymes which are found in the heart, brain, blood vessels, liver, and other organs.
PDE4, encime, ki se nahajajo v srcu, možganih, krvnih žilah, jetrih in drugih organih.
Once-a-day administration has not been evaluated in patients with hepatic insufficiency.
Pri bolnikih z jetrno insuficienco niso ocenjevali odmerjanja enkrat na dan.
In patients receiving concomitant antihypertensive medicinal products, tadalafil may induce a blood pressure decrease.
Tadalafil lahko povzroči znižanje krvnega tlaka pri bolnikih, ki sočasno prejemajo antihipertenzive.
Hepatic insufficiency
Insufienca ledvic
Stroke1 (including haemorrhagic events), Syncope, Transient ischaemic attacks1, Migraine2, Seizures2, Transient amnesia
migrena2, epileptični napadi2, prehodna amnezija
NAME OF THE MEDICINAL PRODUCT CIALIS 20 mg film-coated tablets tadalafil
Navodilo za uporabo CIALIS 20 mg filmsko obložene tablete tadalafil
Respiratory, thoracic and mediastinal disorders Nasal congestion
Žilne bolezni zardevanje hipotenzija3 hipertenzija Bolezni dihal, prsnega koša in mediastinalnega prostora nosna kongestija dispneja, epistaksa
Cardiac disorders1
Srčne bolezni1
A. MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE Name and address of the manufacturers responsible for batch release Lilly S.A., Avda.
Ime in naslov izdelovalcev, odgovornih za sproščanje serije
NAME OF THE MEDICINAL PRODUCT CIALIS 10 mg film-coated tablets tadalafil
Navodilo za uporabo CIALIS 10 mg filmsko obložene tablete tadalafil
Light yellow and almond shaped tablets, marked "C 10" on one side.
CIALIS 10 mg filmsko obložene tablete Tablete svetlo rumene barve in mandljeve oblike, z oznako "C 10" na eni strani.
Nervous system disorders
erektilno disfunkcijo.
There is limited clinical data on the safety of single-dose administration of CIALIS in patients with severe hepatic insufficiency (Child-Pugh Class C).
Pri bolnikih s hudo jetrno insuficienco (razred C po Child-Pughu) je na voljo le malo kliničnih podatkov o varnosti zdravila CIALIS pri enkratnem odmerjanju.
NAME OF THE MEDICINAL PRODUCT CIALIS 2.5 mg film-coated tablets tadalafil
Navodilo za uporabo CIALIS 2,5 mg filmsko obložene tablete tadalafil
Before treatment with CIALIS
Druga zdravila in zdravilo CIALIS
LIST OF EXCIPIENTS lactose
Acetilsalicilna kislina
Posology
UPORABE
NAME OF THE MEDICINAL PRODUCT CIALIS 5 mg film-coated tablets tadalafil
Navodilo za uporabo CIALIS 5 mg filmsko obložene tablete tadalafil
4 and 5.2).
(glejte poglavje 4.3).
Common (seen in 1 to 10 in every 100 patients) - headache, back pain, muscle aches, pain in arms and legs, facial flushing, nasal congestion and indigestion.
- glavobol, bolečina v hrbtu, bolečine v mišicah, bolečina v rokah in nogah, zardevanje v obraz,
These events are usually transient.
Ti dogodki so navadno prehodni.
The mechanism leading to this reaction is unknown.
Mehanizem, ki privede do te reakcije, ni znan.
There is no specific antidote.
Specifičnega antidota ni na voljo.
In addition, it is especially important to tell your doctor if you are also using any of the following medicines:
Poleg tega je posebej pomembno, da zdravniku poveste, če jemljete tudi katero od naslednjih zdravil:
Adults and children older than 1 year
Odrasli in otroci, starejši od enega leta
Not known (frequency cannot be estimated from the available data):
Neznana (pogostnosti iz razpoložljivih podatkov ni mogoče oceniti):
You may be more susceptible to infections.
Morda ste dovzetnejši za okužbe.
Acute pancreatitis has developed in less than 10 % of patients.
Akutni pankreatitis se je razvil pri manj kot 10 % bolnikov.
Treatment is symptomatic and supportive.
Zdravljenje je simptomatsko in podporno.
The causes of these nervous system disorders are unclear.
Vzroki teh bolezni živčevja niso jasni.
If necessary, your doctor will treat your symptoms and will give you supportive care.
Če bo treba, bo zdravnik zdravil vaše simptome in vam zagotovil podporno zdravljenje.
Results of this study are summarised in table 3:
Rezultati te študije so povzeti v preglednici 3:
It should only be given in a hospital setting where appropriate resuscitation equipment is available.
Dajati se sme le v bolnišnicah, kjer je na voljo ustrezna oprema za reanimacijo.
Frequency and symptom
Pogostnost in simptom
This effect was most prominent with a treatment interval of about 120 hours.
Ta učinek je bil najizrazitejši pri intervalu okoli 120 ur med dajanjem zdravil.
As a precautionary measure it is recommended to wait for three months after completion of treatment.
Kot previdnostni ukrep priporočajo, naj se počaka tri mesece po dokončanju zdravljenja.
MRD positive
MRD negativna
Both procedures, however, do not allow for predicting accurately which patients will experience an allergic reaction.
Vendar noben od teh postopkov ne omogoča natančne napovedi, pri katerih bolnikih se bo pojavila alergijska reakcija.
Elderly Limited data are available for the treatment of patients older than 65 years of age.
Za zdravljenje bolnikov, starejših od 65 let, je na voljo malo podatkov.
Asparagine depletion in serum was complete in 11 of 12 patients (92%).
Izčrpanje asparagina v serumu je bilo popolno pri 11 bolnikih od 12 bolnikov (92 %).
E-mail: contact@medac.de
contact@medac.de
Approximately half of the thrombotic events is localised in cerebral vessels.
Približno polovica trombotičnih dogodkov je lokalizirana v možganskih žilah.
A previous intracutaneous test or a small intravenous test dose can be used.
Lahko uporabimo predhoden intrakutani test ali majhen intravenski testni odmerek.
Number of patients
Število bolnikov
Results are shown in table 4.
Rezultati so navedeni v preglednici 4.
Area under the curve (AUC0-72h)
površina pod krivuljo (AUC0-72h)
One unit (U) is defined as the quantity of enzyme required to liberate one µmol ammonia per minute at pH 7.3 and 37°C.
Ena enota (e.) je opredeljena kot količina encima, ki je potrebna, da sprosti en µmol amoniaka na minuto pri pH 7,3 in 37 °C.
You may be given anti-allergic medicines and, if necessary, medicines to stabilise your circulation.
Mogoče boste dobili zdravila proti alergiji in, če bo treba, zdravila za stabilizacijo krvnega obtoka.
All 12 patients (100 %) were in CR after induction treatment.
Vseh 12 bolnikov (100 %) je bilo po indukcijskem zdravljenju v popolni remisiji.
Read all of this leaflet carefully before you are given this medicine because it contains important information for you.
Preden vam dajo to zdravilo, natančno preberite navodilo, ker vsebuje za vas pomembne podatke!
The duration of treatment depends on the specific chemotherapy protocol that is used to treat your disease.
Trajanje zdravljenja je odvisno od posebnega kemoterapevtskega protokola, ki se uporablja za zdravljenje vaše bolezni.
The risk of thrombosis seems to be higher than the risk of bleeding.
Zdi se, da je nevarnost tromboze večja kot nevarnost krvavitve.
The syndrome is generally self-limiting.
Sindrom je navadno samoomejujoč.
For storage conditions after reconstitution and dilution of the medicinal product, see section 6.3.
Za pogoje shranjevanja po rekonstituciji in razredčenju zdravila glejte poglavje 6.3.
• if you are allergic to asparaginase or to any of the other ingredients of this medicine (listed in section 6),
• če ste alergični na asparaginazo ali katero koli sestavino tega zdravila (navedeno v poglavju 6),
Since serum protein is important for the binding and transport function of some active substances, the serum protein level should be monitored regularly.
Ker so serumske beljakovine pomembne za funkcijo vezave in transporta nekaterih zdravilnih učinkovin, je treba redno spremljati raven serumskih beljakovin.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine.
Če ste noseči ali dojite, menite, da bi lahko bili noseči ali načrtujete zanositev, se posvetujte z zdravnikom, preden vzamete to zdravilo.
Tell your doctor immediately and stop taking Spectrila if you experience:
Takoj obvestite zdravnika in prenehajte jemati zdravilo Spectrila, če se pojavijo:
Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000); not known (cannot be estimated from the available data).
Pogostnosti v tej preglednici so opredeljene z naslednjim dogovorom: zelo pogosti (≥1/10); pogosti (≥1/100 do <1/10); občasni (≥1/1.000 do <1/100); redki (≥1/10.000 do <1/1.000); zelo redki (< 1/10.000); neznana (ni mogoče oceniti iz razpoložljivih podatkov).
Thereafter, asparagine serum levels increased again and returned to normal values within 1 - 3 weeks.
Nato se je raven serumskega asparagina spet zviševala in dosegla normalne vrednosti po 1-3 tednih.
Adults and other special populations
Odrasli in druge posebne skupine bolnikov
CI = confidence interval; CSF = cerebrospinal fluid; MRD = minimal residual disease a
CI = interval zaupanja; CSF = cerebrospinalna tekočina; MRD = minimalna rezidualna bolezen a
Plasma ammonia levels should be determined in all patients with unexplained neurologic symptoms or severe and prolonged vomiting.
Koncentracijo amoniaka v plazmi je treba določiti pri vseh bolnikih z nepojasnjenimi nevrološkimi simptomi ali hudim in dolgotrajnim bruhanjem.
Therefore, they require asparagine which diffuses from the extracellular environment.
Zato potrebujejo asparagin, ki difundira iz zunajceličnega okolja.
Increased blood sugar values may require treatment with intravenous fluids and/or insulin.
Pri zvečanih vrednostih krvnega sladkorja bo morda potrebno zdravljenje z intravenskimi tekočinami in/ali insulinom.
There have been isolated reports of fatal outcomes.
Obstajajo posamezna poročila o smrtnih izidih.
Spectrila will not be used:
Zdravilo Spectrila se ne sme uporabiti:
However, treatment with other chemotherapeutic agents should also be taken into consideration.
Vendar pa je treba razmisliti tudi o zdravljenju z drugimi kemoterapevtiki.
Very common Oedema, fatigue
Zelo pogosti edem, utrujenost
What you need to know before you are given Spectrila
Kaj morate vedeti, preden vam bodo dali zdravilo Spectrila
• The medicine also contains sucrose.
• Zdravilo vsebuje tudi saharozo.
If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 °C - 8 °C unless reconstitution/dilution has taken place in controlled and validated aseptic conditions.
Če se zdravilo ne uporabi takoj, je za trajanje shranjevanja med uporabo in razmere shranjevanja pred uporabo odgovoren uporabnik, shranjevanje pa naj bi normalno ne trajalo dalj od 24 ur pri 2 °C - 8 °C, razen če sta bila rekonstitucija in razredčenje opravljena v kontroliranih in validirano aseptičnih razmerah.
- age 6 - 12 months:
- starih 6-12 mesecev:
Table 4: Pharmacokinetic parameters of Spectrila in 14 children/adolescents
Preglednica 4: Farmakokinetični parametri zdravila Spectrila pri 14 otrocih/mladostnikih
If the medicine is not used immediately, the user preparing this medicine is responsible for storage times and conditions to ensure sterility of the product.
Če se zdravilo ne uporabi takoj, je za trajanje shranjevanja in razmere, s katerimi se zagotavlja sterilnost zdravila, odgovoren uporabnik, ki pripravlja to zdravilo.
The dose depends on your body surface area (BSA) which is calculated from your height and weight.
Odmerek bo odvisen od velikosti vaše telesne površine, ki se izračuna iz vaše višine in telesne mase.
Store in a refrigerator (2 °C - 8 °C).
Shranjujte v hladilniku (2 °C-8 °C).
It is unclear whether the RPLS is caused by asparaginase, concomitant treatment or the underlying diseases.
Ni jasno, ali RPLS povzročajo asparaginaza, sočasno zdravljenje ali osnovne bolezni.
Before and during treatment with Spectrila your doctor will carry out blood tests.
Pred zdravljenjem z zdravilom Spectrila in med njim vam bo zdravnik naredil krvne preiskave.
This is important as Spectrila may increase the side effects of other medicines through its effect on the liver which plays an important role in removing medicines from the body.
To je pomembno, ker zdravilo Spectrila lahko zveča neželene učinke drugih zdravil preko svojega vpliva na delovanje jeter, ki ima pomembno vlogo pri odstranjevanju zdravil iz telesa.
• increased blood sugar values.
• zvečane vrednosti krvnega sladkorja.
Asparaginase may also be toxic to normal cells that divide rapidly and are dependent to some degree on exogenous asparagine supply.
Asparaginaza je lahko toksična tudi za normalne celice, ki se hitro delijo in so do neke mere odvisne od eksogene preskrbe z asparaginom.
The time period following treatment with asparaginase when it is safe to become pregnant or father a child is unknown.
Časovno obdobje po zdravljenju z asparaginazo, po katerem postane varno zanositi ali spočeti otroka, ni znano.
Driving and using machines Do not drive when taking this medicine because it may make you feel drowsy, tired or confused.
Ko jemljete to zdravilo, ne upravljajte motornih vozil, ker boste lahko zaradi zdravila zaspani, utrujeni ali zmedeni.
Rare Diabetic ketoacidosis
Redki diabetična ketoacidoza
If you were given more Spectrila than you should If you think that you received too much Spectrila, tell your doctor or nurse as soon as possible.
Če ste prejeli večji odmerek zdravila Spectrila, kot bi smeli Če mislite, da so vam dali preveč zdravila Spectrila, to čim prej povejte zdravniku ali medicinski sestri.
Spectrila should only be used by physicians who are experienced in such treatment protocols.
Zdravilo Spectrila smejo uporabljati le zdravniki, ki imajo izkušnje s tovrstnimi protokoli zdravljenja.
• if you have or previously had inflammation of the pancreas (pancreatitis),
• če imate ali ste kdaj prej imeli vnetje trebušne slinavke (pankreatitis),
Expert advice should first be sought.
Najprej je treba poiskati nasvet specialista.
Adverse reactions are ranked under headings of frequency, the most frequent first.
Neželeni učinki so razvrščeni po pogostnosti, najprej najpogostejši.
Each pack contains either 1 or 5 vials.
Eno pakiranje vsebuje 1 ali 5 vial.
Glucocorticoids and/ or anticoagulants
Glukokortikoidi in/ali antikoagulanti
The probability of the occurrence of allergic reactions increases with the number of administered doses; however, in very rare cases reactions can occur at the first dose of asparaginase.
Verjetnost pojavljanja alergijskih reakcij se zvečuje s številom danih odmerkov, vendar se lahko v zelo redkih primerih reakcije pojavijo že pri prvem odmerku asparaginaze.
What Spectrila is and what it is used for
Kaj je zdravilo Spectrila in za kaj ga uporabljamo
• liver failure which may lead to death
• odpoved jeter, ki lahko povzroči smrt.
Intravenous use after further dilution.
Intravenska uporaba po nadaljnjem razredčenju.
A list of all other side effects is set out below according to how common they are: Very common side effects (may affect more than 1 in 10 people):
Seznam vseh drugih neželenih učinkov je naveden spodaj glede na to, kako pogosti so: Zelo pogosti neželeni učinki (lahko se pojavijo pri več kot 1 od 10 bolnikov):
The lower median activity level on day 33 compared to the former two measurements was in part due to the fact that this last serum sample was taken 4 days after the last infusion of asparaginase instead of three days on the other occasions.
Do manjše ravni mediane aktivnosti na 33. dan kot pri prejšnjih dveh meritvah je prišlo deloma zato, ker je bil zadnji vzorec seruma odvzet 4 dni po zadnji infuziji asparaginaze namesto 3 dni po njej kot v drugih primerih.
• changes in the electroencephalogram (a trace of the electrical activity of your brain)
• spremembe v elektroencefalogramu (posnetek električne aktivnosti vaših možganov),